Hua Medicine Files IND in US for its Novel GKA-based Diabetes Drug Shanghai, China and San Francisco, CA – March 10, 2015 Continuing its momentum after raising $25 million in Series B financing earlier this year, Hua M - Metformin - Document - PDFSEARCH.IO

First Page	Meta Content
	Hua Medicine Files IND in US for its Novel GKA-based Diabetes Drug Shanghai, China and San Francisco, CA – March 10, 2015 Continuing its momentum after raising $25 million in Series B financing earlier this year, Hua M Add to Reading List Document Date: 2015-03-09 22:27:49 Open Document File Size: 80,81 KB Share Result on Facebook City Shanghai / San Francisco / / Company Hua Medicine / / Country China / United States / / Currency USD / / Event FDA Phase / / IndustryTerm experienced / treatment of diabetes / biotechnology / / MedicalCondition CNS disorders / Parkinson’s Disease / Depressive Disorder / hypoglycemia / dyskinesia / diabetes / / MedicalTreatment oral therapy / / Organization US Food and Drug Administration / / Person Li Chen / / Position CEO / / Product China / US / T2DM / 2Q2016 / / Technology drug discovery / drug development / biotechnology / / SocialTag Biguanides Guanidines Glycated hemoglobin Hemoglobins Metformin Health Diabetes mellitus Medicine Diabetes Endocrine system

Hua Medicine Files IND in US for its Novel GKA-based Diabetes Drug Shanghai, China and San Francisco, CA – March 10, 2015 Continuing its momentum after raising $25 million in Series B financing earlier this year, Hua MAdd to Reading List